Literature DB >> 34862966

Improving trial generalizability using observational studies.

Dasom Lee1, Shu Yang1, Lin Dong1, Xiaofei Wang2, Donglin Zeng3, Jianwen Cai3.   

Abstract

Complementary features of randomized controlled trials (RCTs) and observational studies (OSs) can be used jointly to estimate the average treatment effect of a target population. We propose a calibration weighting estimator that enforces the covariate balance between the RCT and OS, therefore improving the trial-based estimator's generalizability. Exploiting semiparametric efficiency theory, we propose a doubly robust augmented calibration weighting estimator that achieves the efficiency bound derived under the identification assumptions. A nonparametric sieve method is provided as an alternative to the parametric approach, which enables the robust approximation of the nuisance functions and data-adaptive selection of outcome predictors for calibration. We establish asymptotic results and confirm the finite sample performances of the proposed estimators by simulation experiments and an application on the estimation of the treatment effect of adjuvant chemotherapy for early-stage non-small-cell lung patients after surgery.
© 2021 The International Biometric Society.

Entities:  

Keywords:  causal inference; double robustness; generalizability; semiparametric efficiency; transportability

Year:  2021        PMID: 34862966      PMCID: PMC9166225          DOI: 10.1111/biom.13609

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  26 in total

1.  Penalized Estimating Functions and Variable Selection in Semiparametric Regression Models.

Authors:  Brent A Johnson; D Y Lin; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2008-06-01       Impact factor: 5.033

2.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

3.  Methodology for comparative effectiveness research: potential and limitations.

Authors:  Edward L Korn; Boris Freidlin
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

4.  The use of propensity scores to assess the generalizability of results from randomized trials.

Authors:  Elizabeth A Stuart; Stephen R Cole; Catherine P Bradshaw; Philip J Leaf
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2001-04-01       Impact factor: 2.483

5.  Outcome-adaptive lasso: Variable selection for causal inference.

Authors:  Susan M Shortreed; Ashkan Ertefaie
Journal:  Biometrics       Date:  2017-03-08       Impact factor: 2.571

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

7.  Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

Authors:  James E Signorovitch; Eric Q Wu; Andrew P Yu; Charles M Gerrits; Evan Kantor; Yanjun Bao; Shiraz R Gupta; Parvez M Mulani
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Robust estimation of encouragement-design intervention effects transported across sites.

Authors:  Kara E Rudolph; Mark J van der Laan
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-10-31       Impact factor: 4.488

9.  Combining Multiple Observational Data Sources to Estimate Causal Effects.

Authors:  Shu Yang; Peng Ding
Journal:  J Am Stat Assoc       Date:  2019-06-11       Impact factor: 5.033

10.  A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.

Authors:  E Massarelli; F Andre; D D Liu; J J Lee; M Wolf; A Fandi; J Ochs; T Le Chevalier; F Fossella; R S Herbst
Journal:  Lung Cancer       Date:  2003-01       Impact factor: 5.705

View more
  2 in total

1.  Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.

Authors:  Fan Li; Ashley L Buchanan; Stephen R Cole
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2022-03-17       Impact factor: 1.680

Review 2.  A Causal Framework for Making Individualized Treatment Decisions in Oncology.

Authors:  Pavlos Msaouel; Juhee Lee; Jose A Karam; Peter F Thall
Journal:  Cancers (Basel)       Date:  2022-08-14       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.